Atlas Trials

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00096304 · TERMINATED

Trial details

NCT number
NCT00096304
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2004-06-08
Primary completion
2006-09-06
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.